GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Acquired by Cwm LLC

Cwm LLC grew its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 22.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 9,959 shares of the company’s stock after purchasing an additional 1,809 shares during the period. Cwm LLC’s holdings in GE HealthCare Technologies were worth $770,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also modified their holdings of GEHC. Chicago Capital LLC increased its position in shares of GE HealthCare Technologies by 2.8% during the third quarter. Chicago Capital LLC now owns 6,081 shares of the company’s stock valued at $414,000 after acquiring an additional 163 shares during the last quarter. Chilton Capital Management LLC increased its holdings in GE HealthCare Technologies by 15.4% in the 4th quarter. Chilton Capital Management LLC now owns 1,227 shares of the company’s stock valued at $95,000 after purchasing an additional 164 shares during the last quarter. Procyon Advisors LLC raised its position in GE HealthCare Technologies by 5.2% in the fourth quarter. Procyon Advisors LLC now owns 3,555 shares of the company’s stock valued at $275,000 after purchasing an additional 175 shares during the period. Meeder Advisory Services Inc. lifted its stake in GE HealthCare Technologies by 5.4% during the fourth quarter. Meeder Advisory Services Inc. now owns 3,634 shares of the company’s stock worth $281,000 after purchasing an additional 185 shares in the last quarter. Finally, Forum Financial Management LP boosted its position in shares of GE HealthCare Technologies by 3.9% during the third quarter. Forum Financial Management LP now owns 4,989 shares of the company’s stock worth $339,000 after buying an additional 186 shares during the period. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Up 3.1 %

NASDAQ GEHC opened at $88.94 on Tuesday. GE HealthCare Technologies Inc. has a 52 week low of $62.35 and a 52 week high of $94.50. The firm has a 50 day moving average of $88.98 and a two-hundred day moving average of $78.75. The stock has a market capitalization of $40.59 billion, a PE ratio of 29.45, a price-to-earnings-growth ratio of 3.00 and a beta of 0.95. The company has a quick ratio of 0.83, a current ratio of 1.05 and a debt-to-equity ratio of 1.18.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Tuesday, February 6th. The company reported $1.18 EPS for the quarter, topping analysts’ consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The firm had revenue of $5.20 billion during the quarter, compared to the consensus estimate of $5.09 billion. During the same quarter in the previous year, the firm posted $1.31 earnings per share. The company’s revenue was up 5.3% compared to the same quarter last year. As a group, research analysts expect that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be given a dividend of $0.03 per share. The ex-dividend date is Thursday, April 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.13%. GE HealthCare Technologies’s dividend payout ratio is presently 3.97%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the company. Mizuho boosted their price objective on GE HealthCare Technologies from $96.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, April 11th. Evercore ISI increased their price target on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a research report on Thursday, April 4th. Morgan Stanley lifted their price objective on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a report on Monday, February 12th. Argus increased their target price on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a report on Monday, April 1st. Finally, UBS Group upgraded shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and boosted their price target for the stock from $66.00 to $88.00 in a research note on Monday, February 12th. Four analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $95.09.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.